339 related articles for article (PubMed ID: 16955057)
21. Serial monitoring of brain natriuretic peptide concentrations for drug therapy management in patients with chronic heart failure.
Gallegos PJ; Maclaughlin EJ; Haase KK
Pharmacotherapy; 2008 Mar; 28(3):343-55. PubMed ID: 18294114
[TBL] [Abstract][Full Text] [Related]
22. Case studies in advanced monitoring: OptiVol.
Tang WH
Rev Cardiovasc Med; 2006; 7 Suppl 1():S62-6. PubMed ID: 17009449
[TBL] [Abstract][Full Text] [Related]
23. Proactive monitoring: implications of implantable devices for future heart failure management.
Daleiden-Burns A; Stiles P
Crit Care Nurs Q; 2007; 30(4):321-8. PubMed ID: 17873568
[TBL] [Abstract][Full Text] [Related]
24. Optimizing outcomes in the patient with acute decompensated heart failure.
Mehra MR
Am Heart J; 2006 Mar; 151(3):571-9. PubMed ID: 16504617
[TBL] [Abstract][Full Text] [Related]
25. Circulating natriuretic peptide levels in acute heart failure.
Maisel A
Rev Cardiovasc Med; 2007; 8 Suppl 5():S13-21. PubMed ID: 18192949
[TBL] [Abstract][Full Text] [Related]
26. OptiVol fluid status monitoring with an implantable cardiac device: a heart failure management system.
Yamokoski LM; Haas GJ; Gans B; Abraham WT
Expert Rev Med Devices; 2007 Nov; 4(6):775-80. PubMed ID: 18035943
[TBL] [Abstract][Full Text] [Related]
27. Integration of automatic intrathoracic fluid content measurement into clinical decision making in patients with congestive heart failure.
Knackstedt C; Mischke K; Schimpf T; Waringer J; Fache K; Frechen D; Gramley F; Kelm M; Schauerte P
Pacing Clin Electrophysiol; 2008 Aug; 31(8):961-7. PubMed ID: 18684251
[TBL] [Abstract][Full Text] [Related]
28. Natriuretic peptide testing for heart failure therapy guidance in the inpatient and outpatient setting.
Green SM; Green JA; Januzzi JL
Am J Ther; 2009; 16(2):171-7. PubMed ID: 19300043
[TBL] [Abstract][Full Text] [Related]
29. Usefulness of B-type natriuretic peptide levels in predicting hemodynamic and clinical decompensation.
Taub PR; Daniels LB; Maisel AS
Heart Fail Clin; 2009 Apr; 5(2):169-75. PubMed ID: 19249686
[TBL] [Abstract][Full Text] [Related]
30. Cost effectiveness of the B type natriuretic peptide, electrocardiography, and portable echocardiography for the assessment of patients from the community with suspected heart failure.
Lim TK; Dwivedi G; Hayat S; Collinson PO; Senior R
Echocardiography; 2007 Mar; 24(3):228-36. PubMed ID: 17313633
[TBL] [Abstract][Full Text] [Related]
31. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.
Felker GM; Hasselblad V; Hernandez AF; O'Connor CM
Am Heart J; 2009 Sep; 158(3):422-30. PubMed ID: 19699866
[TBL] [Abstract][Full Text] [Related]
32. Outpatient monitoring and treatment of chronic heart failure guided by amino-terminal pro-B-type natriuretic peptide measurement.
Troughton RW; Richards AM
Am J Cardiol; 2008 Feb; 101(3A):72-5. PubMed ID: 18243863
[TBL] [Abstract][Full Text] [Related]
33. Message in a bottle--natriuretic peptide determination as a noninvasive measurement of pulmonary capillary wedge pressure?
Collinson PO
Int J Clin Pract; 2008 Feb; 62(2):177-8. PubMed ID: 18199274
[No Abstract] [Full Text] [Related]
34. [Cardiopulmonary failure in Duchenne muscular dystrophy--pathophysiology and management].
Ishihara T
Rinsho Shinkeigaku; 2003 Nov; 43(11):761-4. PubMed ID: 15152458
[TBL] [Abstract][Full Text] [Related]
35. Acute decompensated heart failure: pathophysiology and treatment.
Onwuanyi A; Taylor M
Am J Cardiol; 2007 Mar; 99(6B):25D-30D. PubMed ID: 17378992
[TBL] [Abstract][Full Text] [Related]
36. Brain natriuretic peptide in heart failure and beyond.
Mowla MM; Bustami BB
Saudi Med J; 2006 Oct; 27(10):1457-61. PubMed ID: 17013463
[TBL] [Abstract][Full Text] [Related]
37. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: application of natriuretic peptides.
Pfister R; Schneider CA
Eur Heart J; 2009 Feb; 30(3):382-3; author reply 383. PubMed ID: 19109350
[No Abstract] [Full Text] [Related]
38. [The role of natriuretic peptides in heart failure].
Ancona R; Limongelli G; Pacileo G; Miele T; Rea A; Roselli T; Masarone D; Messina S; Palmieri R; Golia E; Iacomino M; Gala S; Calabrò P; Di Salvo G; Calabrò R
Minerva Med; 2007 Oct; 98(5):591-602. PubMed ID: 18043566
[TBL] [Abstract][Full Text] [Related]
39. FPIN's clinical inquiries: brain natriuretic peptide for ruling out heart failure.
Cullan A; Grover M; Hitchcock K
Am Fam Physician; 2011 Jun; 83(11):1333-4. PubMed ID: 21661716
[No Abstract] [Full Text] [Related]
40. NT-proBNP in monitoring treatment of patients with congestive heart failure.
Al-Meslmani BM; Fahoum SK; Shamia MG
Clin Lab; 2007; 53(1-2):35-9. PubMed ID: 17323823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
